Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement

Rony Dahan, Bryan C. Barnhart, Fubin Li, Aaron P. Yamniuk, Alan J. Korman, Jeffrey V. Ravetch

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science